Scientists uncover clues to deadly sepsis complication
NCT ID NCT03721809
First seen Jan 24, 2026 · Last updated May 12, 2026 · Updated 15 times
Summary
This study looked at 27 adults in intensive care to understand the inflammation behind macrophage activation syndrome (MAS) triggered by bacterial sepsis. MAS is a serious condition with a high death rate, and current treatments are not well-defined. By measuring specific inflammatory markers, researchers hope to find safer, targeted therapies for these fragile patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACROPHAGE ACTIVATION SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Rouen
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.